XBiotech Inc Cash Flow Reinvestment Rate

Latest as of December 2022: 1.45x

XBiotech Inc cash flow reinvestment rate. XBiotech Inc (XBIT) has a Cash Flow Reinvestment Rate of 1.45x as of December 2022, reinvesting $3.91 Million (capex $132.00K plus investments $-3.77 Million) from operating cash flow of $2.70 Million. Explore how well can XBiotech Inc service its debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

1.45x
(Capex + Investments) / Operating CF

Total Reinvested

$3.91 Million
Capex + Investments

Operating Cash Flow

$2.70 Million
USD

Capital Expenditures

$132.00K
USD

Cash Flow Reinvestment Rate of XBiotech Inc (2021–2021)

Cash flow reinvestment rate of XBiotech Inc from 2021 to 2021. Historical reinvestment intensity for XBiotech Inc across 1 annual periods. Explore XBIT capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

XBiotech Inc Cash Flow Reinvestment Rate by Year (2021–2021)

XBiotech Inc cash flow reinvestment rate by year from 2021 to 2021. Year-by-year capital reinvestment analysis for XBiotech Inc. For the full cash flow conversion analysis, see XBiotech Inc cash flow conversion.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2021 0.10x $7.05 Million $69.44 Million $3.52 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow